Article

Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-Up

2025-04-03

Abstract excerpt

<h4>Importance</h4> The clinical behavior of well-differentiated pancreatic neuroendocrine tumors (PanNETs) is difficult to predict. <h4>Objective</h4> To define more accurately prognosticators for patients with a surgically resected PanNET. <h4>Design</h4> The pathology and Ki-67 immunolabeling index of PanNETs resected from 904 patients was correlated with patient outcome. <h4>Setting</h4> Academic tertiary care...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b41574f6-e6a4-5ccc-9058-d5dcd1575c39
DOI: 10.1101/2025.04.01.25325055

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Prognostic Features in Surgically Resected Well-Differentiated Pancreatic Neuroendocrine Tumors: An Analysis of 904 Patients with 7882 Person-Years of Follow-UpDOI 10.1101/2025.04.01.25325055Read

Morphologic Variants of Pancreatic Neuroendocrine Tumors: Clinicopathologic Analysis and Prognostic Stratification.Semantic proximity Read

Neoplasms of the Neuroendocrine Pancreas: An Update in the Classification, Definition, and Molecular Genetic AdvancesSemantic proximity Read

Pancreatic Neuroendocrine Neoplasms: 2020 Update on Pathologic and Imaging Findings and Classification.Semantic proximity Read

Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine TumorsSemantic proximity Read

Cancer of the Liver, Intrahepatic Bile Ducts, Gallbladder, Exocrine and Neuroendocrine Pancreas: 20-Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes A Systematic Review of 367,420 Cases for Diagnosis Years 1973-2014: (SEER*Stat 8.3.4).Semantic proximity Read

Molecular Basis of Pancreatic Neuroendocrine TumorsSemantic proximity Read

Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?Semantic proximity Read

Clinical implications of cell-of-origin epigenetic characteristics in non-functional pancreatic neuroendocrine tumors.Semantic proximity Read

Pancreatic Neuroendocrine Neoplasms: Landscape and Horizon.Semantic proximity Read

Pancreatic neuroendocrine neoplasms (pNENs): Genetic and environmental biomarkers for risk of occurrence and prognosis.Semantic proximity Read

Immunohistochemistry based molecular subtyping of pancreatic neuroendocrine tumor correlates with clinicopathological outcome: A single institute retrospective studySemantic proximity Read

Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the FutureSemantic proximity Read